📷 Image: Wikimedia Commons / Harris & Ewing, photographer
Food
FDA Issues Warning to Jammu Kashmir Food Businesses Over Misleading Labels
✍️ Kashmir Life
🗓 13 Oct 2026, 03:02 AM
👁 14
The Food and Drug Administration has cautioned food companies in Jammu and Kashmir to avoid misleading labels and unsubstantiated health claims, emphasizing compliance with regulatory standards.
The Food and Drug Administration (FDA) has issued a formal warning to food businesses operating in Jammu and Kashmir, urging them to refrain from using misleading labels and unverified health claims on their products. The notice highlights that such practices violate the country's labeling regulations and can mislead consumers.
Under the warning, the FDA cited several instances where labels suggested health benefits that were not supported by scientific evidence. The agency stressed that any claim about disease prevention or treatment must be backed by approved studies and approved by the regulatory authority.
Businesses that fail to comply with the labeling guidelines may face penalties, product recalls, or even suspension of licenses. The FDA has also announced that it will conduct inspections to ensure adherence to the new directives.
Industry representatives have expressed concern about the enforcement process but acknowledge the need for transparency. They are expected to cooperate with the FDA to revise packaging and marketing materials in line with the updated standards.
Under the warning, the FDA cited several instances where labels suggested health benefits that were not supported by scientific evidence. The agency stressed that any claim about disease prevention or treatment must be backed by approved studies and approved by the regulatory authority.
Businesses that fail to comply with the labeling guidelines may face penalties, product recalls, or even suspension of licenses. The FDA has also announced that it will conduct inspections to ensure adherence to the new directives.
Industry representatives have expressed concern about the enforcement process but acknowledge the need for transparency. They are expected to cooperate with the FDA to revise packaging and marketing materials in line with the updated standards.